Looks like we just found some cash (Tunisian refunds) to put toward the costs of the Fausse Point drill costs. Maybe there is still life in the old VIL yet.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%